Table 1—

Profile of the 590 patients

Variable% (n)
Age-group  
 <50 years 14.7 (87) 
 50–69 years 65.6 (387) 
 ≥70 years 19.7 (116) 
Sex  
 M 50.2 (296) 
 F 49.8 (294) 
Ethnic group  
 Chinese 80.7 (476) 
 Malay 6.9 (41) 
 Indian 11.4 (67) 
 Others 1.0 (6) 
With hypertension 44.4 (262) 
Duration of diabetes  
 <10 years 65.9 (389) 
 ≥10 years 31.4 (201) 
Treatment of diabetes  
 Diet only 11.4 (67) 
 Oral medications 84.9 (501) 
 Oral and insulin 1.2 (7) 
 Insulin only 2.5 (15) 
HbA1c (%)*  
 <7 41.1 (239) 
 7 to <9 31.6 (184) 
 ≥9 27.3 (159) 
Fasting plasma glucose (mmol/l)*  
 <6.7 17.4 (102) 
 6.7 to <7.8 21.9 (128) 
 ≥7.8 60.7 (355) 
2-h postprandial glucose (mmol/l)*  
 <10.0 47.3 (202) 
 10 to <11.1 11.7 (50) 
 ≥11.1 41.0 (175) 
Albuminuria (mg/mmol urine creatinine)  
 Normo- (<2) 63.9 (375) 
 Micro- (2–20) 30.8 (181) 
 Macro- (>20) 5.3 (31) 
Variable% (n)
Age-group  
 <50 years 14.7 (87) 
 50–69 years 65.6 (387) 
 ≥70 years 19.7 (116) 
Sex  
 M 50.2 (296) 
 F 49.8 (294) 
Ethnic group  
 Chinese 80.7 (476) 
 Malay 6.9 (41) 
 Indian 11.4 (67) 
 Others 1.0 (6) 
With hypertension 44.4 (262) 
Duration of diabetes  
 <10 years 65.9 (389) 
 ≥10 years 31.4 (201) 
Treatment of diabetes  
 Diet only 11.4 (67) 
 Oral medications 84.9 (501) 
 Oral and insulin 1.2 (7) 
 Insulin only 2.5 (15) 
HbA1c (%)*  
 <7 41.1 (239) 
 7 to <9 31.6 (184) 
 ≥9 27.3 (159) 
Fasting plasma glucose (mmol/l)*  
 <6.7 17.4 (102) 
 6.7 to <7.8 21.9 (128) 
 ≥7.8 60.7 (355) 
2-h postprandial glucose (mmol/l)*  
 <10.0 47.3 (202) 
 10 to <11.1 11.7 (50) 
 ≥11.1 41.0 (175) 
Albuminuria (mg/mmol urine creatinine)  
 Normo- (<2) 63.9 (375) 
 Micro- (2–20) 30.8 (181) 
 Macro- (>20) 5.3 (31) 
*

Information not available for all subjects.

Close Modal

or Create an Account

Close Modal
Close Modal